# Chemistry

> Chemistry is a VC fund backing Software and Information Technology. See 20 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: VC Fund
- Total investments: 20
- Last investment: Sep 2026
- Lead investor: 45%
- Fund size: $10M
- Last fund: Jul 2026
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/company/104849401/admin/dashboard/
- X (Twitter): https://x.com/chemistry_fund
- Website: https://www.chemistry.vc

Chemistry is a VC fund focused on Software and Information Technology. Chemistry VC is a venture capital firm that focuses on seed and Series A investments in innovative startups. The company leverages institutional experience to support founders in scaling their businesses effectively.

## Contacts

5 contacts available for Chemistry. Shizune tracks 3 team members at Chemistry. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/chemistry-vc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 8 | 40% |
| Information Technology | 7 | 35% |
| Artificial Intelligence | 6 | 30% |
| Infrastructure | 2 | 10% |
| SaaS | 1 | 5% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 10 | 50% |
| Seed | 4 | 20% |
| Series B | 2 | 10% |
| Series D | 2 | 10% |
| Series C | 1 | 5% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ethan Kurzweil | Founder & Managing Partner | 46 | https://shizune.co/investors/profile/ethan-kurzweil |
| Kristina Shen-Gupta | Managing Partner | 26 | https://shizune.co/investors/profile/kristina-shen |
| Mark Goldberg | Managing Partner | 38 | https://shizune.co/investors/profile/mark-goldberg-3 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Proximal | Proximal builds AI training data and environments to improve software engineering agents and autonomous coding systems. | $15M | Seed | Sep 29, 2026 | https://www.proximal.ai/ |
| Liquid Compute | Liquid Compute is a financial infrastructure platform that creates a regulated marketplace for AI computing power. | $15M | Seed | Sep 15, 2026 | https://liquidcompute.com |
| Wafer | Wafer is an AI optimization platform that automatically accelerates AI models by generating efficient custom GPU kernels. | $40M | Series A | Sep 01, 2026 | https://www.wafer.ai |
| Atoms | Atoms is a robotics startup that develops industrial robotics and physical AI systems designed to automate tasks across mining, transport, and food-related operations. The company builds specialized, task-oriented machines rather than general-purpose robots, focusing on improving productivity in environments that involve physical labor andlogistics. Its technology centers on applying software-like principles to real-world systems, using robotics, sensors, and data-driven models to manage and execute industrial processes. The company structures its activities into distinct segments aligned with key industries, including food infrastructure, mining operations, and transportation systems. In the food sector, it develops automated infrastructure that supports preparation and production workflows, while in mining, it focuses on increasing operational efficiency through robotic systems designed for extraction and site activities. Its transport-related efforts include building a foundational robotic platform, described as a “wheelbase,” that supports mobility and deployment of machines in logistics and industrial settings. | $1.7B | Seed | Jul 22, 2026 | https://atoms.co |
| Meticulous | Meticulous is a tool for detecting bugs in web applications. The company was founded in 2021. | $15M | Series A | Jul 15, 2026 | https://www.meticulous.ai |
| Assort Health | Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $120M | Series C | Jun 24, 2026 | https://assorthealth.com/ |
| Nova Intelligence | Nova Intelligence is the leading agentic AI platform for SAP teams. Our AI agents help enterprises document and understand custom code, reduce complexity by leveraging SAP standard whenever possible, and modernize and build new applications—all with Clean Core compliant, upgrade-safe principles. SAP teams using Nova double their productivity. Theteam behind Nova includes the co-inventor of SAP HANA, an AI researcher from Google DeepMind, and the former CIO of Cargill. The company is backed by SAP's investment arm and top Silicon Valley VCs. | $31.5M | Series A | May 05, 2026 | https://novaintelligence.com |
| Fathom Therapeutics | Fathom Therapeutics, previously known as Atommap, is a biotechnology company focused on designing therapeutic molecules through computational drug discovery approaches. The company develops models that simulate biomolecular and protein motion to better understand how proteins behave and interact, enabling the identification of new therapeuticstrategies. Its platform combines generative design, predictive modeling, and computational assays to create and evaluate molecular candidates for their binding affinity and functional effects. By leveraging these simulations, it supports drug discovery processes such as hit identification, lead optimization, and the design of targeted molecules, including degraders and molecular glues. The company also collaborates with partners by providing molecular designs, predictive insights, and co-development opportunities for advancing therapeutic candidates. | $47M | Series A | Apr 27, 2026 | https://www.atommap.com |
| Comfy | Comfy develops and maintains open-source software centered on generative AI workflows, primarily through its core product, ComfyUI, a node-based application for building and managing AI-driven content creation pipelines. The platform enables users to construct visual workflows that generate images, videos, 3D assets, and audio by connecting modularcomponents, enabling repeatable, adjustable outputs rather than one-off prompts. Its tools include a workflow engine, extension manager, custom node registry, and supporting interfaces such as command-line utilities and automation features, which together form a flexible ecosystem for AI development and usage. The company emphasizes enabling users to create and customize their own solutions, often without requiring coding, and supports both local execution and cloud-based usage depending on user needs. Comfy's software is used by a broad range of individuals and teams, including developers, artists, and organizations, to build reproducible and scalable generative AI workflows. | $30M | Series B | Apr 24, 2026 | https://www.comfy.org |
| Yuzu Health | Automating health plan administration | $35M | Series A | Apr 06, 2026 | https://yuzu.health |

10 of 20 investments shown.

## Co-investors
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 6 deals together
- [First Round Capital](https://shizune.co/investors/profile/first-round-capital) — VC Fund, 5 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 5 deals together
- [A*](https://shizune.co/investors/profile/a-capital-4ec5) — VC Fund, 3 deals together
- [Abstract](https://shizune.co/investors/profile/a-list-ventures) — VC Fund, 3 deals together
- [Coatue](https://shizune.co/investors/profile/coatue) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Chemistry invest in?

Chemistry invests primarily in Software, Information Technology and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Chemistry?

Public channels for Chemistry include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Chemistry?

The team at Chemistry includes Ethan Kurzweil (Founder & Managing Partner), Kristina Shen-Gupta (Managing Partner) and Mark Goldberg (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co